These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9588103)

  • 1. [Clinical aspects of use of angiotensin-converting enzyme inhibitors in patients with arterial hypertension].
    Widimský J
    Cas Lek Cesk; 1998 Mar; 137(6):175-8. PubMed ID: 9588103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Angiotensin converting enzyme inhibitors in the treatment of arterial hypertension].
    Widimský J
    Vnitr Lek; 1995 Aug; 41(8):560-4. PubMed ID: 7483342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical aspects of use of beta-blockers in the treatment of arterial hypertension].
    Widimský J
    Vnitr Lek; 1997 Apr; 43(4):221-5. PubMed ID: 9601840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies.
    Brilla CG; Rupp H; Maisch B
    Herz; 2003 Dec; 28(8):744-53. PubMed ID: 14689110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibitors after renal transplantation.
    Bravo P; Felgueiras J; Santos C; Oliveira C; Ponce P
    Transplant Proc; 2008 Apr; 40(3):740-2. PubMed ID: 18455003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension.
    Bramlage P
    Expert Opin Pharmacother; 2009 Aug; 10(11):1755-67. PubMed ID: 19538001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noscapine suppresses angiotensin converting enzyme inhibitors-induced cough.
    Mooraki A; Jenabi A; Jabbari M; Zolfaghari MI; Javanmardi SZ; Mahmoudian M; Bastani B
    Nephrology (Carlton); 2005 Aug; 10(4):348-50. PubMed ID: 16109080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current possibilities of ACE inhibitor and ARB combination in arterial hypertension and its complications.
    Kolasinska-Malkowska K; Filipiak KJ; Gwizdala A; Tykarski A
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):759-71. PubMed ID: 18510491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late onset angiotensin-converting enzyme induced angioedema: case report and review of the literature.
    Guo X; Dick L
    J Okla State Med Assoc; 1999 Feb; 92(2):71-3. PubMed ID: 10024785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A prospective study on the cough mechanism induced by angiotensin-converting enzyme inhibitors in patients with hypertension].
    Ye RJ; He QY; Gai J; Shang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):581-4. PubMed ID: 15498266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibitor induced cough: experience in Siriraj Hospital.
    Buranakitjaroen P; Sriussadaporn S; Phoojaroenchanachai M; Sangprasert P; Saravich S
    J Med Assoc Thai; 2003 Jul; 86(7):647-54. PubMed ID: 12948260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renin-angiotensin-aldosterone system inhibition: pharmacologic rationale and evaluations of drug combinations].
    Andréjak M; Slama M; Hary L
    Therapie; 1998; 53(3):291-300. PubMed ID: 9773129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Different effect of angiotensin convertase inhibitors and AT1 receptor blockers on renal function in patients with chronic renal failure: report of two cases].
    Litwin M; Prokurat S
    Pol Merkur Lekarski; 2000 Apr; 8(46):295-6. PubMed ID: 10897659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Angiotensin converting enzyme inhibitors in arterial hypertension and cardiac failure. The question of the dose].
    González-Juanatey JR
    Med Clin (Barc); 2000; 114 Suppl 2():24-7. PubMed ID: 10916802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
    Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
    J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Converting enzyme inhibitors and arterial hypertension].
    Mimran A
    Rev Prat; 1988 Mar; 38(10):604-12. PubMed ID: 3375762
    [No Abstract]   [Full Text] [Related]  

  • 17. Spironolactone further reduces urinary albumin excretion and plasma B-type natriuretic peptide levels in hypertensive type II diabetes treated with angiotensin-converting enzyme inhibitor.
    Ogawa S; Takeuchi K; Mori T; Nako K; Ito S
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):477-9. PubMed ID: 16700881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison between the effects of angiotensin-converting enzyme inhibitors and angiotensin II antagonists].
    Asmar R; Madonna O; Brisac AM; Benetos A; Laurent S
    Therapie; 1998; 53(3):253-70. PubMed ID: 9773125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation.
    L'Allier PL; Ducharme A; Keller PF; Yu H; Guertin MC; Tardif JC
    J Am Coll Cardiol; 2004 Jul; 44(1):159-64. PubMed ID: 15234426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.